Huntington S Chorea — Patent Landscape
1
Approved drugs
252
Active US patents
63/100
Avg vulnerability
$1.1B
Annual revenue covered
Originators in Huntington S Chorea
Cliff calendar — next 15 years
22
31
23
33
23
34
132
36
44
38
8
41
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Austedo
DEUTETRABENAZINE
|
Teva | 252 | 63 | $1.1B | 2031-04-03 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 9550780 | Austedo | method of use | 75 | 2033-09-18 |
| 9550780 | Austedo | method of use | 75 | 2033-09-18 |
| 9550780 | Austedo | method of use | 75 | 2033-09-18 |
| 9550780 | Austedo | method of use | 75 | 2033-09-18 |
| 9550780 | Austedo | method of use | 75 | 2033-09-18 |
| 12016858 | Austedo | method of use | 75 | 2036-03-07 |
| 11446291 | Austedo | method of use | 75 | 2036-03-07 |
| 12016858 | Austedo | method of use | 75 | 2036-03-07 |
| 11357772 | Austedo | method of use | 75 | 2036-03-07 |
| 12016858 | Austedo | method of use | 75 | 2036-03-07 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8524733 | Austedo | composition of matter | 10 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 10 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 10 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 18 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 18 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 18 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 23 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 23 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 23 | 2031-04-03 |
| 8524733 | Austedo | composition of matter | 23 | 2031-04-03 |
Related
- Huntington S Chorea — full disease profile
- AI Patent Landscape Report — type "huntington s chorea" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner